Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer DOI Creative Commons
Amy Body, Luxi Lal, Sriganesh Srihari

et al.

Vaccine, Journal Year: 2024, Volume and Issue: unknown, P. 126547 - 126547

Published: Dec. 1, 2024

The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of response. epidemiology in Australia offered unique opportunities study cancer populations minimal community exposure SARS-CoV-2.

Language: Английский

Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity DOI
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao

et al.

Mucosal Immunology, Journal Year: 2024, Volume and Issue: 17(2), P. 201 - 210

Published: Jan. 25, 2024

Language: Английский

Citations

9
Durability of immune responses to SARS-CoV-2 infection and vaccination DOI
Mehul S. Suthar

Seminars in Immunology, Journal Year: 2024, Volume and Issue: 73, P. 101884 - 101884

Published: May 1, 2024

Language: Английский

Citations

4
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer DOI Creative Commons
Amy Body, Luxi Lal, Sriganesh Srihari

et al.

Vaccine, Journal Year: 2024, Volume and Issue: unknown, P. 126547 - 126547

Published: Dec. 1, 2024

The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of response. epidemiology in Australia offered unique opportunities study cancer populations minimal community exposure SARS-CoV-2.

Language: Английский

Citations

1